OSMAX
Price
$37.67
Change
-$0.45 (-1.18%)
Updated
Jul 31 closing price
Net Assets
2.39B
TCMIX
Price
$19.52
Change
-$0.18 (-0.91%)
Updated
Jul 31 closing price
Net Assets
119.77M
Interact to see
Advertisement

OSMAX vs TCMIX

OSMAX vs TCMIX Comparison Chart in %
View a ticker or compare two or three
VS
OSMAX vs. TCMIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSMAX is a StrongBuy and TCMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OSMAX has more cash in the bank: 2.39B vs. TCMIX (120M). OSMAX pays higher dividends than TCMIX: OSMAX (1.36) vs TCMIX (1.07). OSMAX was incepted earlier than TCMIX: OSMAX (29 years) vs TCMIX (14 years). OSMAX (1.42) is less costly to investors than TCMIX (1.10). TCMIX is a more actively managed with annual turnover of: 60.00 vs. OSMAX (52.00). OSMAX has a lower initial minimum investment than TCMIX: OSMAX (1000) vs TCMIX (5000000). TCMIX annual gain was more profitable for investors over the last year : 10.49 vs. OSMAX (-8.88). TCMIX return over 5 years is better than : 8.13 vs. OSMAX (-36.97).
OSMAXTCMIXOSMAX / TCMIX
Total Expense Ratio1.421.05135%
Annual Report Gross Expense Ratio1.421.10129%
Fund Existence29 years14 years-
Gain YTD6.1137.13586%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.39B120M1,991%
Annual Yield % from dividends1.361.07127%
Returns for 1 year-8.8810.49-85%
Returns for 3 years-8.2345.26-18%
Returns for 5 years-36.978.13-455%
Returns for 10 years3.5768.415%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWWFX41.880.26
+0.62%
Fidelity Worldwide
PEQLX44.96-0.03
-0.07%
Putnam Large Cap Value R5
HRSCX24.46-0.06
-0.24%
Carillon Eagle Small Cap Growth A
PIEQX22.30-0.17
-0.76%
T. Rowe Price International Eq Index
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H